Therefore, in line with our results, it can be suggested that even in originally ER-negative invasive carcinoma cases, estrogen levels in the patient and ER status in the stromal cells may have a role in the degree of tumor response to chemotherapy. The gene discussed is ESR1; the disease is neoplasm.